Works matching IS 17762596 AND DT 2019 AND VI 14 AND IP 2

Results: 12

Comparative Efficacy of CDK4/6 Inhibitors Plus Aromatase Inhibitors Versus Fulvestrant for the First-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer: A Network Meta-Analysis.
Published in:
2019
By:
- Guo, Qianqian;
- Lin, Xiaojie;
- Ye, Lingling;
- Xu, Rui;
- Dai, Yan;
- Zhang, Yuzhu;
- Chen, Qianjun
Publication type:
journal article
Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies.
Published in:
2019
By:
- Lucas, Fabienne;
- Woyach, Jennifer A.
Publication type:
journal article
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.
Published in:
2019
By:
- Takagi, Toshio;
- Fukuda, Hironori;
- Kondo, Tsunenori;
- Ishihara, Hiroki;
- Yoshida, Kazuhiko;
- Kobayashi, Hirohito;
- Iizuka, Junpei;
- Okumi, Masayoshi;
- Ishida, Hideki;
- Tanabe, Kazunari
Publication type:
journal article
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
Published in:
2019
By:
- Raschi, Emanuel;
- Mazzarella, Alessandra;
- Antonazzo, Ippazio Cosimo;
- Bendinelli, Nicolò;
- Forcesi, Emanuele;
- Tuccori, Marco;
- Moretti, Ugo;
- Poluzzi, Elisabetta;
- De Ponti, Fabrizio
Publication type:
journal article
Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.
Published in:
2019
By:
- Chen, Xiang;
- Yao, JiaXi;
- Liu, Li;
- Zheng, WenZhong;
- Hu, XiaoYi;
- Zhu, YanJun;
- Wang, Hang;
- Guo, JianMing
Publication type:
journal article
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.
Published in:
2019
By:
- Hong, Xiaonan;
- Song, Yuqin;
- Huang, Huiqiang;
- Bai, Bing;
- Zhang, Huilai;
- Ke, Xiaoyan;
- Shi, Yuankai;
- Zhu, Jun;
- Lu, Guodong;
- Liebscher, Stefan;
- Cai, Chunxiao
Publication type:
journal article
Rucaparib: A Review in Ovarian Cancer.
Published in:
2019
By:
- Shirley, Matt
Publication type:
journal article
Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models.
Published in:
2019
By:
- Yee, Pei San;
- Zainal, Nur Syafinaz;
- Gan, Chai Phei;
- Lee, Bernard K. B.;
- Mun, Kein Seong;
- Abraham, Mannil Thomas;
- Ismail, Siti Mazlipah;
- Abdul Rahman, Zainal Ariff;
- Patel, Vyomesh;
- Cheong, Sok Ching
Publication type:
journal article
Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
Published in:
2019
By:
- Su, Yudong;
- Long, Xiang;
- Song, Yang;
- Chen, Peng;
- Li, Shanqing;
- Yang, Huaxia;
- Wu, Pancheng;
- Wang, Yanyu;
- Bing, Zhongxing;
- Cao, Zhili;
- Cao, Lei;
- Wu, Yijun;
- Zhang, Zhe;
- Liu, Jing;
- Li, Bing;
- Xiang, Jianxing;
- Ma, Ke;
- Zhang, Tengfei;
- Zhang, Lu;
- Mao, Xinru
Publication type:
journal article
The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies.
Published in:
2019
By:
- Marquardt, Jens U.;
- Saborowski, Anna;
- Czauderna, Carolin;
- Vogel, Arndt
Publication type:
journal article
EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR.
Published in:
2019
By:
- Buder, Anna;
- Setinek, Ulrike;
- Hochmair, Maximilian J.;
- Schwab, Sophia;
- Kirchbacher, Klaus;
- Keck, Andrea;
- Burghuber, Otto C.;
- Pirker, Robert;
- Filipits, Martin
Publication type:
journal article
Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib.
Published in:
2019
By:
- Zhao, Yiming;
- Wang, Shuyuan;
- Zhang, Bo;
- Qiao, Rong;
- Xu, Jianlin;
- Zhang, Lele;
- Zhang, Yanwei;
- Han, Baohui
Publication type:
journal article